Fgaem2Mjfk
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Fgaem2Mjfk |
| Name: |
fibrinogen alpha chain; endonuclease-mediated mutation 2, Matthew J Flick |
| MGI ID: |
MGI:7378191 |
| Synonyms: |
Fga270 line B |
| Gene: |
Fga Location: Chr3:82933460-82940934 bp, + strand Genetic Position: Chr3, 36.96 cM, cytoband F1
|
| Alliance: |
Fgaem2Mjfk page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Hypomorph) |
| Mutation: |
|
Nucleotide substitutions
|
| |
|
Mutation details: CRISPR/Cas9 technology introduced a premature termination codon (ACGT to TTAA change) in exon 5 at residue 271 to generate a truncation mutation in the alphaC region of fibrinogen. Plasma fibrinogen levels in homozygotes are approximately 10% of wild-type levels. The mutant fibrinogen is able to assemble into a mature fibrinogen molecule. Two lines, A and B were generated. Two lines, A and B were generated. This record represents line B.
(J:330337)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Fga Mutation: |
45 strains or lines available
|
|
| Original: |
J:330337 Hur WS, et al., Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutation. Blood. 2022 Mar 3;139(9):1374-1388 |
| All: |
1 reference(s) |
|